J Mark FitzGerald

3.4k citations

46 papers · 2.3k indexed · 1 hit paper · h-index 22

Immunology and Allergy top 1%
- Allergic Rhinitis and Sensitization 5
Physiology top 1%
- Asthma and respiratory diseases 19
Pulmonary and Respiratory Medicine top 2%
- Respiratory and Cough-Related Research 10
- Chronic Obstructive Pulmonary Disease (COPD) Research 10
- Respiratory Support and Mechanisms 4
Immunology top 5%
Physical Therapy, Sports Therapy and Rehabilitation top 5%
Infectious Diseases
- Tuberculosis Research and Epidemiology 6
Epidemiology
- Mycobacterium research and diagnosis 4
General Health Professions
- Healthcare cost, quality, practices 3

Co-authors: Louis‐Philippe Boulet Mohsen Sadatsafavi Donald W. Cockcroft Paul M. O’Byrne Beth E. Davis Gail M. Gauvreau Carlo A. Marra Richard Leigh
Cited by: Immunology and Allergy Physiology Pulmonary and Respiratory Medicine
Journals: New England Journal of Medicine (2 papers)American Journal of Respiratory and Critical Care Medicine (2 papers)CHEST Journal (2 papers)
Partner nations: Canada United States Australia

In The Last Decade

J Mark FitzGerald

45 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by J Mark FitzGerald

Since Specialization

Citations

This map shows the geographic impact of J Mark FitzGerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Mark FitzGerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Mark FitzGerald more than expected).

Fields of papers citing papers by J Mark FitzGerald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Mark FitzGerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Mark FitzGerald. The network helps show where J Mark FitzGerald may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J Mark FitzGerald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J Mark FitzGerald Line = papers co-authored together J Mark FitzGerald links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials Respiratory Research ·Wenjia Chen,Helen K. Reddel,J Mark FitzGerald,Richard Beasley,Christer Janson,Mohsen Sadatsafavi	2023	6
2	Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma The Journal of Allergy and Clinical Immunology In Practice ·Ian Pavord,Yamo Deniz,Jonathan Corren,Thomas B. Casale,J Mark FitzGerald,Kenji Izuhara,Nadia Daizadeh,Benjamin Ortiz,Robert R. Johnson,Sivan Harel,Michel Djandji,Ledia Goga,Nora Crikelair,Paul J. Rowe,William W. Busse	2022	54
3	Assessing factors influencing smoking and smoking cessation within Chinese communities in the Greater Vancouver Area: A qualitative exploratory study Tobacco Prevention & Cessation ·Noah Tregobov,Iraj Poureslami,Jessica Shum,Niloufar Aran,Austin McMillan,J Mark FitzGerald	2020	7
4	<p>Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada</p> International Journal of COPD ·Hamid Tavakoli,KATE JOHNSON,J Mark FitzGerald,Don D. Sin,Andrea S. Gershon,Tetyana Kendzerska,Mohsen Sadatsafavi	2019	18
5	Benralizumab Reduces Exacerbations in Japanese Patients with Severe, Uncontrolled Asthma: Subgroup Analysis of the Calima Trial Journal of Allergy and Clinical Immunology ·J Mark FitzGerald,Ken Ohta,Mitsuru Adachi,Yuji Tohda,Tadashi Kamei,Motokazu Kato,Masayuki Takanuma,Tadahiro Kakuno,Nobuyuki Imai,Yanping Wu,Magnus Aurivillius,Mitchell Goldman	2017	1
6	Assessing the effect of culturally specific audiovisual educational interventions on attaining self-management skills for chronic obstructive pulmonary disease in Mandarin- and Cantonese-speaking patients: a randomized controlled trial International Journal of COPD ·Iraj Poureslami,S.Y.L. Kwan,Stephen Lam,Nadia Khan,J Mark FitzGerald	2016	32
7	The Projected Epidemic of Chronic Obstructive Pulmonary Disease Hospitalizations over the Next 15 Years. A Population-based Perspective American Journal of Respiratory and Critical Care Medicine ·Amir Khakban,Don D. Sin,J Mark FitzGerald,Bruce M. McManus,Raymond T. Ng,Zsuzsanna Hollander,Mohsen Sadatsafavi	2016	86
8	TUBERCULOSIS screening preferences of Healthcare workers in South Africa: a best-worst scaling study to analyze variation by Occupation Value in Health ·Nathan N. O’Hara,Lilla M. Roy,Lyndsay M. O’Hara,Jerry Spiegel,Larry D. Lynd,J Mark FitzGerald,Annalee Yassi,Letshego E. Nophale,Carlo A. Marra	2015	1
9	A Systems Approach to Chronic Obstructive Pulmonary Disease (COPD) Management in Vancouver and the Lower Mainland (LM): The COPD Lower Mainland Innovation and Integration Fund (LMIIF) Project CHEST Journal ·Erin M. Toplak,J Mark FitzGerald	2010	1
10	Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma American Journal of Respiratory and Critical Care Medicine ·Gail M. Gauvreau,Louis‐Philippe Boulet,Donald W. Cockcroft,J Mark FitzGerald,Chris Carlsten,Beth E. Davis,Francine Deschesnes,MyLinh Duong,Billie L. Durn,Karen Howie,Linda Hui,Marion T. Kasaian,Kieran J. Killian,Tara X. Strinich,Richard M. Watson,Yuli Nathalie,Simon Zhou,Donald G. Raible,Paul M. O’Byrne	2010	181
11	Falls in people with chronic obstructive pulmonary disease: An observational cohort study Respiratory Medicine ·Marc Roig,Janice J. Eng,Donna L. MacIntyre,Jeremy Road,J Mark FitzGerald,Jennifer Burns,W. Darlene Reid	2010	129
12	Direct Health Care Costs Associated with Asthma in British Columbia Canadian Respiratory Journal ·Mohsen Sadatsafavi,Larry D. Lynd,Carlo A. Marra,Bruce Carleton,Wan C. Tan,Sean D. Sullivan,J Mark FitzGerald	2010	123
13	Cost‐Effectiveness of Continuous Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnea‐Hypopnea in British Columbia Canadian Respiratory Journal ·MCY Tan,NT Ayas,Alan Mulgrew,Lisa Cortes,J Mark FitzGerald,JA Fleetham,Michael Schulzer,C. Francis Ryan,Reza Ghaeli,P Cooperx,Carlo A. Marra	2008	37
14	The impact of obstructive sleep apnea and daytime sleepiness on work limitation Sleep Medicine ·Alan Mulgrew,C. Francis Ryan,John A. Fleetham,R. Cheema,Noam Y. Fox,Mieke Koehoorn,J Mark FitzGerald,Carlo A. Marra,Najib Ayas	2007	175
15	The risk of death associated with delayed coronary artery bypass surgery BMC Health Services Research ·Boris Sobolev,Adrian R. Levy,Lisa Kuramoto,Robert Hayden,James M. Brophy,J Mark FitzGerald	2006	25
16	Do Longer Delays for Coronary Artery Bypass Surgery Contribute to Preoperative Mortality in Less Urgent Patients? Medical Care ·Boris Sobolev,Adrian R. Levy,Lisa Kuramoto,Robert Hayden,J Mark FitzGerald	2006	18
17	Research Gaps in Protecting Healthcare Workers From SARS and Other Respiratory Pathogens: An Interdisciplinary, Multi-Stakeholder, Evidence-Based Approach Journal of Occupational and Environmental Medicine ·Annalee Yassi,David Moore,J Mark FitzGerald,Philip Bigelow,Chun‐Yip Hon,Elizabeth Bryce	2005	68
18	Time on wait lists for coronary bypass surgery in British Columbia, Canada, 1991 – 2000 BMC Health Services Research ·Adrian R. Levy,Boris Sobolev,Robert Hayden,Michael L. Kiely,J Mark FitzGerald,Martin T. Schechter	2005	27
19	Tuberculosis among Aboriginal and Nonaboriginal Persons in British Columbia Canadian Respiratory Journal ·L Wang,Kukuh Noertjojo,R. K. Elwood,J Mark FitzGerald	2000	8
20	The Effect of Adding Ipratropium Bromide to Salbutamol in the Treatment of Acute Asthma CHEST Journal ·Stephan Lanes,Jeffrey Garrett,Charles Wentworth,J Mark FitzGerald,Jill P. Karpel	1998	52

About J Mark FitzGerald

J Mark FitzGerald is a scholar working on Issues, ethics and legal aspects, Physiology and Immunology and Allergy, having authored 46 papers that have together received 2.3k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Tuberculosis Research and Epidemiology (6 papers), Allergic Rhinitis and Sensitization (5 papers), Respiratory Support and Mechanisms (4 papers), Mycobacterium research and diagnosis (4 papers) and Healthcare cost, quality, practices (3 papers). The work is most often cited by research in Immunology and Allergy (377 citations), Physiology (1.4k citations) and Pulmonary and Respiratory Medicine (1.0k citations). J Mark FitzGerald has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Louis‐Philippe Boulet, Mohsen Sadatsafavi, Donald W. Cockcroft, Paul M. O’Byrne, Beth E. Davis, Gail M. Gauvreau, Carlo A. Marra, Richard Leigh, Michael Boedigheimer and Michael R. Comeau. Their work appears in journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact